June 2018
THE PHASE 1B OF OUR MYASTHENIA GRAVIS THERAPEUTIC VACCINE DEMONSTRATES AN EXCELLENT SAFETY PROFILE
February 2016
160209 Curavac Plans Ph2 Studies
December 2015
June 2014
THE PHASE 1B OF OUR MYASTHENIA GRAVIS THERAPEUTIC VACCINE DEMONSTRATES AN EXCELLENT SAFETY PROFILE
160209 Curavac Plans Ph2 Studies